Vor Biopharma Inc. (VOR) Tops Q1 EPS by 11c

Vor Biopharma Inc. (NASDAQ: VOR) reported Q1 EPS of ($0.43), $0.11 better than the analyst estimate of ($0.54).

For earnings history and earnings-related data on Vor Biopharma Inc. (VOR) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• CoStar Group acquires Zonda for $800M, adding new home data
• ZKH Group Limited (ZKH) Reports Q2 EPS of $0.04